EVOLOCUMAB

EVOLOCUMAB was reported 165049 times

EVOLOCUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 122 0.6816
1 INCORRECT DISPOSAL OF PRODUCT 1746 0.5371
2 LOW DENSITY LIPOPROTEIN DECREASED 738 0.5208
3 DEVICE DIFFICULT TO USE 33254 0.5019
4 PRODUCT COMMUNICATION ISSUE 2936 0.3325
5 LOW DENSITY LIPOPROTEIN ABNORMAL 202 0.3295
6 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2523 0.3287
7 DRUG DOSE OMISSION BY DEVICE 24856 0.3171
8 TYPE IIA HYPERLIPIDAEMIA 71 0.3034
9 PRODUCT KNOWLEDGE DEFICIT 205 0.2621
10 BLOOD CHOLESTEROL DECREASED 463 0.2484
11 COMPUTERISED TOMOGRAM HEART ABNORMAL 20 0.2439
12 LIPOPROTEIN (A) INCREASED 77 0.2355
13 LACK OF ADMINISTRATION SITE ROTATION 53 0.1738
14 ACCIDENTAL EXPOSURE TO PRODUCT 17173 0.1665
15 INJECTION SITE INDENTATION 352 0.1624
16 LOW DENSITY LIPOPROTEIN INCREASED 1207 0.1558
17 OCCUPATIONAL EXPOSURE TO PRODUCT 958 0.1489
18 PRODUCT PREPARATION ERROR 2845 0.1383
19 DEVICE USE ERROR 4408 0.1267
20 INCORRECT DOSE ADMINISTERED BY DEVICE 3120 0.1189
21 LACK OF INJECTION SITE ROTATION 199 0.1136
22 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22690 0.1119
23 INCORRECT DOSE ADMINISTERED BY PRODUCT 172 0.1074
24 HIGH DENSITY LIPOPROTEIN ABNORMAL 25 0.1064
25 VASCULAR STENT STENOSIS 44 0.1045
26 RUBBER SENSITIVITY 157 0.1025
27 APPLICATION SITE MASS 27 0.0985
28 DEVICE DISPENSING ERROR 115 0.0974
29 OBSTRUCTIVE SLEEP APNOEA SYNDROME 139 0.0953
30 FEAR OF INJECTION 647 0.0906
31 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2878 0.0851
32 MYOGLOBIN BLOOD INCREASED 126 0.0824
33 PRODUCT STORAGE ERROR 6709 0.0766
34 INJURY ASSOCIATED WITH DEVICE 1524 0.0748
35 HIGH DENSITY LIPOPROTEIN INCREASED 70 0.0704
36 PERCUTANEOUS CORONARY INTERVENTION 19 0.0667
37 BLOOD TRIGLYCERIDES DECREASED 22 0.0653
38 INJECTION SITE BRUISING 4954 0.0620
39 RHINORRHOEA 3676 0.0568
40 BLOOD TRIGLYCERIDES ABNORMAL 48 0.0548
41 VASCULAR STENT OCCLUSION 22 0.0546
42 INJECTION SITE HAEMORRHAGE 4136 0.0517
43 INJECTION SITE DISCOMFORT 530 0.0503
44 LIPIDS ABNORMAL 36 0.0497
45 STENT PLACEMENT 401 0.0497
46 BLOOD CHOLESTEROL ABNORMAL 223 0.0482
47 PLANTAR FASCIITIS 150 0.0447
48 INJECTION SITE DISCOLOURATION 553 0.0442
49 INJECTION SITE HYPOAESTHESIA 62 0.0433
50 BRAIN NATRIURETIC PEPTIDE INCREASED 128 0.0415
51 HIGH DENSITY LIPOPROTEIN DECREASED 133 0.0399
52 INJECTION SITE PARAESTHESIA 61 0.0397
53 INFLUENZA LIKE ILLNESS 3225 0.0391
54 CARDIAC OPERATION 335 0.0389
55 INJECTION SITE LACERATION 24 0.0374
56 INJECTION SITE VESICLES 226 0.0373
57 INJECTION SITE MASS 1372 0.0371
58 INJECTION SITE PAIN 11254 0.0367
59 LIPIDS INCREASED 74 0.0366
60 VASCULAR GRAFT 105 0.0364
61 INTERCEPTED PRODUCT STORAGE ERROR 128 0.0358
62 CORONARY ARTERY BYPASS 205 0.0356
63 BLOOD TRIGLYCERIDES INCREASED 616 0.0348
64 PRODUCT ADMINISTRATION ERROR 700 0.0346
65 PARANASAL SINUS HYPERSECRETION 127 0.0332
66 CORONARY ARTERIAL STENT INSERTION 168 0.0331
67 MYALGIA 5484 0.0322
68 AORTIC VALVE REPLACEMENT 39 0.0311
69 SUBCLAVIAN VEIN THROMBOSIS 35 0.0307
70 INJECTION SITE MACULE 21 0.0307
71 CAROTID ARTERIOSCLEROSIS 31 0.0300
72 CATHETERISATION CARDIAC 133 0.0300
73 DRUG DOSE OMISSION 4929 0.0298
74 EXPOSURE VIA SKIN CONTACT 756 0.0291
75 MUSCLE DISORDER 236 0.0291
76 ADVERSE REACTION 385 0.0290
77 BLOOD CHOLESTEROL INCREASED 1337 0.0287
78 HEART VALVE REPLACEMENT 42 0.0284
79 INJECTION SITE SWELLING 2103 0.0274
80 INJECTION SITE SCAB 26 0.0270
81 VASCULAR OCCLUSION 57 0.0270
82 INJECTION SITE INJURY 148 0.0267
83 MUSCLE DISCOMFORT 20 0.0255
84 MEDICAL DEVICE IMPLANTATION 39 0.0248
85 UPPER-AIRWAY COUGH SYNDROME 204 0.0247
86 BACK PAIN 5658 0.0243
87 INJECTION SITE URTICARIA 542 0.0221
88 DEVICE DEFECTIVE 372 0.0214
89 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 381 0.0208
90 GLYCOSYLATED HAEMOGLOBIN DECREASED 33 0.0205
91 INJECTION SITE HYPERSENSITIVITY 63 0.0201
92 SINUS DISORDER 395 0.0199
93 UNDERDOSE 1422 0.0195
94 HYPOACUSIS 834 0.0194
95 INJECTION SITE INDURATION 249 0.0192
96 EAR CONGESTION 52 0.0192
97 ESSENTIAL HYPERTENSION 35 0.0191
98 DEVICE ISSUE 1700 0.0189
99 PERIPHERAL ARTERY OCCLUSION 26 0.0185
100 MUSCLE SPASMS 3326 0.0181
101 GLYCOSYLATED HAEMOGLOBIN INCREASED 455 0.0180
102 SENSATION OF FOREIGN BODY 151 0.0179
103 INJECTION SITE RASH 546 0.0178
104 CORONARY ARTERY OCCLUSION 244 0.0178
105 INJECTION RELATED REACTION 29 0.0176
106 SECRETION DISCHARGE 219 0.0175
107 CAROTID ARTERY OCCLUSION 62 0.0170
108 COLONOSCOPY 37 0.0168
109 MUSCLE FATIGUE 70 0.0165
110 CAROTID ARTERY DISEASE 21 0.0165
111 APPLICATION SITE HAEMORRHAGE 45 0.0165
112 OROPHARYNGEAL PAIN 1520 0.0164
113 ARTERIAL DISORDER 31 0.0162
114 INJECTION SITE ERYTHEMA 1994 0.0161
115 IMPLANTABLE DEFIBRILLATOR INSERTION 21 0.0159
116 MUSCULOSKELETAL DISORDER 302 0.0159
117 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 739 0.0158
118 INJECTION SITE EXTRAVASATION 192 0.0155
119 INJECTION SITE PRURITUS 1031 0.0154
120 INJECTION SITE SCAR 43 0.0151
121 INCREASED UPPER AIRWAY SECRETION 77 0.0150
122 EYE OPERATION 69 0.0150
123 RESPIRATORY TRACT CONGESTION 232 0.0146
124 MUSCULOSKELETAL PAIN 764 0.0146
125 SINUS PAIN 34 0.0146
126 SNEEZING 327 0.0146
127 CARDIAC ABLATION 26 0.0145
128 ARTERIAL OCCLUSIVE DISEASE 114 0.0145
129 SPINAL OPERATION 178 0.0144
130 NASOPHARYNGITIS 2641 0.0143
131 EXOSTOSIS 130 0.0142
132 ANGIOPLASTY 21 0.0141
133 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 239 0.0141
134 ARTERIOSCLEROSIS 132 0.0140
135 CATHETER PLACEMENT 26 0.0140
136 ANGINA UNSTABLE 91 0.0140
137 THERAPY NON-RESPONDER 627 0.0139
138 PRODUCT TEMPERATURE EXCURSION ISSUE 71 0.0138
139 GLUCOSE TOLERANCE IMPAIRED 81 0.0137
140 INCREASED TENDENCY TO BRUISE 126 0.0137
141 UNEVALUABLE EVENT 1024 0.0135
142 SHOULDER ARTHROPLASTY 36 0.0134
143 RESPIRATORY SYMPTOM 38 0.0133
144 INTERMITTENT CLAUDICATION 21 0.0132
145 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86 0.0132
146 MIDDLE EAR EFFUSION 29 0.0131
147 INJECTION SITE INFLAMMATION 65 0.0130
148 CORONARY ARTERY STENOSIS 65 0.0129
149 NASAL DISORDER 34 0.0128
150 INCORRECT DRUG ADMINISTRATION RATE 54 0.0127
151 INJECTION SITE IRRITATION 161 0.0126
152 THERAPY INTERRUPTED 902 0.0126
153 CARDIAC PACEMAKER INSERTION 75 0.0126
154 CAROTID ARTERY STENOSIS 43 0.0123
155 BACK DISORDER 198 0.0122
156 DEVICE FAILURE 184 0.0121
157 PAIN IN EXTREMITY 3554 0.0120
158 BLOOD CALCIUM ABNORMAL 20 0.0120
159 SINUS CONGESTION 162 0.0120
160 NASAL CONGESTION 701 0.0119
161 OBSTRUCTIVE AIRWAYS DISORDER 132 0.0119
162 THROAT CLEARING 44 0.0117
163 MUSCLE TIGHTNESS 188 0.0116
164 BLOOD CREATINE PHOSPHOKINASE INCREASED 333 0.0116
165 MUSCULOSKELETAL DISCOMFORT 199 0.0116
166 VENOUS OCCLUSION 21 0.0115
167 PRODUCT SUPPLY ISSUE 82 0.0115
168 POLYMYALGIA RHEUMATICA 36 0.0113
169 DRY THROAT 115 0.0113
170 JOINT LOCK 32 0.0113
171 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 46 0.0113
172 DYSPHONIA 651 0.0111
173 REHABILITATION THERAPY 43 0.0111
174 BRAIN FOG 174 0.0111
175 GROIN PAIN 97 0.0110
176 SHOULDER OPERATION 47 0.0110
177 MOBILITY DECREASED 788 0.0110
178 AORTIC STENOSIS 38 0.0109
179 BODY TEMPERATURE ABNORMAL 20 0.0109
180 LIMB OPERATION 52 0.0108
181 INFLUENZA 1205 0.0108
182 RHINITIS 87 0.0108
183 TRIGGER FINGER 44 0.0108
184 NECK SURGERY 25 0.0107
185 VIRAL UPPER RESPIRATORY TRACT INFECTION 51 0.0107
186 THERAPEUTIC RESPONSE UNEXPECTED 481 0.0107
187 STENOSIS 20 0.0106
188 INTENTIONAL PRODUCT MISUSE 927 0.0106
189 DRUG EFFECT INCOMPLETE 384 0.0106
190 PRODUCT DISPENSING ERROR 230 0.0106
191 ANGINA PECTORIS 302 0.0105
192 PRODUCT DISPENSING ISSUE 45 0.0105
193 RASH PRURITIC 570 0.0105
194 ARTERIOSCLEROSIS CORONARY ARTERY 69 0.0104
195 PRURITUS GENERALISED 225 0.0104
196 NECK PAIN 579 0.0103
197 MUSCULAR WEAKNESS 1171 0.0103
198 PRODUCT DOSE OMISSION 671 0.0103
199 LABORATORY TEST ABNORMAL 302 0.0102
200 PAPULE 72 0.0102
201 INJECTION SITE WARMTH 209 0.0102
202 AORTIC VALVE STENOSIS 18 0.0101
203 PARANASAL SINUS DISCOMFORT 38 0.0100
204 APPLICATION SITE SWELLING 50 0.0100
205 APPLICATION SITE DISCOMFORT 18 0.0100
206 ARTHRALGIA 4143 0.0100
207 DISABILITY 197 0.0100
208 LIMB DISCOMFORT 308 0.0099
209 ADVERSE EVENT 913 0.0099
210 FOREIGN BODY IN THROAT 31 0.0098
211 VASCULAR STENT THROMBOSIS 20 0.0098
212 MULTIPLE USE OF SINGLE-USE PRODUCT 55 0.0098
213 KNEE OPERATION 95 0.0096
214 INJECTION SITE REACTION 656 0.0095
215 BLOOD GLUCOSE INCREASED 1783 0.0095
216 APHONIA 132 0.0094
217 CORONARY ARTERY DISEASE 286 0.0094
218 PRODUCT ADMINISTRATION INTERRUPTED 74 0.0094
219 PHARYNGEAL SWELLING 92 0.0094
220 HEAD DISCOMFORT 166 0.0094
221 OROPHARYNGEAL DISCOMFORT 84 0.0093
222 DIABETES MELLITUS 707 0.0093
223 HERNIA REPAIR 24 0.0092
224 ILL-DEFINED DISORDER 556 0.0091
225 SLUGGISHNESS 93 0.0091
226 ARTHRITIS 713 0.0091
227 SCIATICA 144 0.0090
228 PRODUCT PREPARATION ISSUE 59 0.0090
229 CHEMOTHERAPY 34 0.0090
230 EAR SWELLING 19 0.0090
231 MEMORY IMPAIRMENT 1229 0.0089
232 CATARACT OPERATION 53 0.0089
233 RASH VESICULAR 43 0.0089
234 UPPER RESPIRATORY TRACT INFECTION 409 0.0088
235 KNEE ARTHROPLASTY 185 0.0088
236 SINUS HEADACHE 52 0.0087
237 SPINAL STENOSIS 36 0.0087
238 SEASONAL ALLERGY 123 0.0087
239 PHARYNGEAL DISORDER 25 0.0087
240 LIMB MASS 19 0.0086
241 DEMENTIA 240 0.0086
242 DRUG EFFECT LESS THAN EXPECTED 127 0.0086
243 MACULAR DEGENERATION 101 0.0084
244 HIP ARTHROPLASTY 129 0.0084
245 SKIN ODOUR ABNORMAL 33 0.0084
246 ARTHROPOD BITE 62 0.0084
247 COUGH 2340 0.0083
248 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 143 0.0083
249 EAR DISORDER 38 0.0083
250 BLOOD PRESSURE ABNORMAL 165 0.0083
251 BLOOD GLUCOSE ABNORMAL 153 0.0083
252 EMBOLISM VENOUS 25 0.0082
253 GALLBLADDER OPERATION 33 0.0081
254 MIGRAINE WITH AURA 22 0.0081
255 EAR PAIN 156 0.0080
256 TONGUE DISCOMFORT 34 0.0080
257 EXFOLIATIVE RASH 21 0.0080
258 MUSCLE RUPTURE 31 0.0080
259 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1426 0.0079
260 DEVICE MALFUNCTION 556 0.0079
261 CARDIAC FLUTTER 51 0.0079
262 PULSE ABNORMAL 19 0.0079
263 BONE PAIN 462 0.0079
264 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 561 0.0079
265 INJECTION SITE HAEMATOMA 114 0.0078
266 CONTUSION 752 0.0078
267 AORTIC ARTERIOSCLEROSIS 20 0.0078
268 MUSCLE STRAIN 67 0.0077
269 HEPATIC PAIN 33 0.0077
270 SURGERY 450 0.0077
271 SPINAL FUSION SURGERY 31 0.0076
272 EAR DISCOMFORT 78 0.0076
273 UPPER RESPIRATORY TRACT CONGESTION 22 0.0076
274 BLADDER PAIN 24 0.0076
275 MYOCARDIAL INFARCTION 1310 0.0075
276 AUTOIMMUNE DISORDER 73 0.0075
277 MUSCULOSKELETAL CHEST PAIN 115 0.0074
278 MYOPATHY 64 0.0074
279 VARICOSE VEIN 38 0.0074
280 URINE ODOUR ABNORMAL 43 0.0073
281 THROAT IRRITATION 328 0.0073
282 PANCREATIC DISORDER 36 0.0073
283 EOSINOPHILIA 128 0.0073
284 HAEMORRHAGIC DIATHESIS 26 0.0073
285 FEELING ABNORMAL 1736 0.0072
286 GAIT INABILITY 241 0.0072
287 PRODUCT LABEL CONFUSION 42 0.0072
288 PULMONARY PAIN 21 0.0072
289 DEVICE PHYSICAL PROPERTY ISSUE 55 0.0072
290 CARDIAC DISORDER 671 0.0072
291 GOUT 128 0.0071
292 JOINT STIFFNESS 187 0.0071
293 PNEUMOTHORAX 113 0.0071
294 INTERCEPTED MEDICATION ERROR 33 0.0071
295 GASTROINTESTINAL PAIN 78 0.0071
296 PARAESTHESIA ORAL 102 0.0071
297 THERAPY CESSATION 362 0.0070
298 DYSPNOEA EXERTIONAL 265 0.0070
299 HEART RATE ABNORMAL 39 0.0070
300 PERIPHERAL VASCULAR DISORDER 36 0.0070
301 ADVERSE DRUG REACTION 623 0.0069
302 MUSCLE ATROPHY 87 0.0069
303 VENTRICULAR HYPOKINESIA 22 0.0068
304 MENISCUS INJURY 42 0.0068
305 BOWEL MOVEMENT IRREGULARITY 52 0.0068
306 SINUSITIS 695 0.0068
307 INJECTION SITE PAPULE 31 0.0068
308 BLOOD BLISTER 21 0.0067
309 RASH GENERALISED 173 0.0067
310 CHEST DISCOMFORT 684 0.0067
311 EYE DISORDER 219 0.0067
312 HIP SURGERY 36 0.0066
313 HEART VALVE INCOMPETENCE 19 0.0066
314 NERVE COMPRESSION 61 0.0066
315 ANGIOPATHY 37 0.0066
316 SPONDYLITIS 24 0.0066
317 LACRIMATION INCREASED 196 0.0065
318 MUSCULOSKELETAL STIFFNESS 568 0.0065
319 AORTIC ANEURYSM 49 0.0064
320 FRUSTRATION TOLERANCE DECREASED 52 0.0064
321 THROAT TIGHTNESS 174 0.0064
322 ANEURYSM 32 0.0064
323 TRANSIENT ISCHAEMIC ATTACK 216 0.0064
324 RENAL TRANSPLANT 23 0.0064
325 NEEDLE ISSUE 185 0.0063
326 MYOSITIS 57 0.0063
327 TENDON PAIN 48 0.0063
328 RASH PAPULAR 142 0.0063
329 OVERWEIGHT 34 0.0063
330 LIP SWELLING 208 0.0062
331 NERVOUSNESS 325 0.0062
332 PULMONARY CONGESTION 82 0.0062
333 HEPATIC ENZYME ABNORMAL 31 0.0062
334 GAIT DISTURBANCE 1187 0.0062
335 VEIN DISORDER 31 0.0062
336 RENAL PAIN 65 0.0061
337 SWELLING FACE 399 0.0061
338 PERIPHERAL SWELLING 941 0.0061
339 AMNESIA 397 0.0061
340 CEREBROVASCULAR ACCIDENT 1033 0.0061
341 PRODUCTIVE COUGH 291 0.0061
342 BRONCHITIS 450 0.0061
343 NASAL DRYNESS 38 0.0061
344 PERIORBITAL SWELLING 34 0.0060
345 LIVER FUNCTION TEST INCREASED 129 0.0060
346 FIBROMYALGIA 146 0.0060
347 SWOLLEN TONGUE 187 0.0060
348 INTRACRANIAL ANEURYSM 24 0.0060
349 CEREBRAL DISORDER 44 0.0059
350 BLOOD PRESSURE INCREASED 902 0.0059
351 DYSSTASIA 170 0.0058
352 CONCUSSION 45 0.0058
353 ARTHROPATHY 323 0.0058
354 CHEST PAIN 1075 0.0058
355 SKIN HAEMORRHAGE 86 0.0058
356 HYPERSENSITIVITY 1075 0.0058
357 DIZZINESS POSTURAL 56 0.0058
358 URTICARIA 966 0.0058
359 RESPIRATORY DISORDER 172 0.0057
360 DIVERTICULITIS 159 0.0057
361 BLOOD CALCIUM INCREASED 50 0.0057
362 TENDONITIS 88 0.0057
363 ACUTE CORONARY SYNDROME 47 0.0057
364 VISUAL IMPAIRMENT 695 0.0056
365 APPENDICECTOMY 20 0.0056
366 FACIAL PAIN 50 0.0056
367 TENDERNESS 58 0.0056
368 EXERCISE TOLERANCE DECREASED 32 0.0056
369 BURNING SENSATION 388 0.0055
370 ILLNESS 568 0.0055
371 URINE ABNORMALITY 25 0.0055
372 ABNORMAL FAECES 45 0.0055
373 THYROID MASS 21 0.0055
374 TOOTHACHE 99 0.0055
375 PHARYNGEAL OEDEMA 84 0.0055
376 INJECTION SITE NODULE 60 0.0054
377 BLOOD TEST ABNORMAL 76 0.0054
378 RENAL FUNCTION TEST ABNORMAL 25 0.0054
379 TENDON INJURY 20 0.0054
380 ONYCHOCLASIS 37 0.0054
381 GUILLAIN-BARRE SYNDROME 26 0.0054
382 HEPATIC STEATOSIS 100 0.0054
383 RESPIRATION ABNORMAL 37 0.0054
384 MASS 75 0.0054
385 NEURALGIA 130 0.0053
386 PROSTATOMEGALY 21 0.0053
387 FATIGUE 4161 0.0053
388 ROTATOR CUFF SYNDROME 68 0.0053
389 BLOOD GLUCOSE FLUCTUATION 58 0.0053
390 TINNITUS 243 0.0053
391 LIMB INJURY 143 0.0053
392 FOOT OPERATION 26 0.0052
393 LETHARGY 302 0.0052
394 SKIN LACERATION 57 0.0052
395 SKIN MASS 35 0.0052
396 HYPOAESTHESIA ORAL 79 0.0052
397 DIALYSIS 74 0.0052
398 RASH ERYTHEMATOUS 249 0.0052
399 PAIN 3198 0.0052
400 NASAL DISCOMFORT 41 0.0052
401 INTERVERTEBRAL DISC DISORDER 22 0.0051
402 PRESYNCOPE 125 0.0051
403 DIZZINESS 2563 0.0051
404 FLANK PAIN 48 0.0051
405 SCRATCH 54 0.0051
406 CHOLECYSTECTOMY 58 0.0051
407 ATRIAL FIBRILLATION 494 0.0051
408 MUSCLE INJURY 42 0.0051
409 CHAPPED LIPS 22 0.0051
410 HOSPITALISATION 778 0.0051
411 THYROID DISORDER 78 0.0051
412 PAIN IN JAW 143 0.0050
413 RASH MACULAR 176 0.0050
414 PRODUCT DOSE OMISSION ISSUE 1475 0.0050
415 HEADACHE 3133 0.0050
416 ACUTE MYOCARDIAL INFARCTION 147 0.0050
417 INTENTIONAL DOSE OMISSION 142 0.0050
418 BLOOD TESTOSTERONE DECREASED 34 0.0050
419 GASTRIC INFECTION 19 0.0050
420 VERTIGO 300 0.0049
421 DRUG DELIVERY SYSTEM MALFUNCTION 25 0.0049
422 WEIGHT LOSS POOR 25 0.0049
423 THERAPEUTIC PRODUCT EFFECT DECREASED 219 0.0049
424 COLITIS MICROSCOPIC 23 0.0049
425 FLATULENCE 275 0.0048
426 FEELING COLD 135 0.0048
427 DIABETIC NEUROPATHY 24 0.0048
428 POLLAKIURIA 202 0.0048
429 WHEEZING 287 0.0048
430 CATARACT 288 0.0048
431 INJECTION SITE DISCHARGE 26 0.0048
432 NEUROPATHY PERIPHERAL 458 0.0048
433 IRRITABLE BOWEL SYNDROME 103 0.0048
434 ASTHENIA 1802 0.0048
435 WEIGHT INCREASED 1071 0.0048
436 SPINAL PAIN 56 0.0048
437 ACCIDENT 57 0.0048
438 AUTOIMMUNE THYROIDITIS 18 0.0048
439 CARDIAC VALVE DISEASE 27 0.0047
440 DEAFNESS UNILATERAL 26 0.0047
441 TENDON RUPTURE 58 0.0047
442 ABDOMINAL PAIN UPPER 964 0.0047
443 URINARY TRACT DISORDER 21 0.0047
444 RENAL DISORDER 217 0.0047
445 ABDOMINAL DISCOMFORT 778 0.0046
446 GASTRIC DISORDER 159 0.0046
447 AUTOIMMUNE HEPATITIS 32 0.0046
448 DEAFNESS 120 0.0046
449 INTERVERTEBRAL DISC PROTRUSION 100 0.0046
450 DEVICE USE ISSUE 80 0.0046
451 OFF LABEL USE 3997 0.0046
452 RASH 1989 0.0046
453 FOOD CRAVING 24 0.0046
454 SPUTUM DISCOLOURED 43 0.0045
455 BURSITIS 55 0.0045
456 PROSTATIC DISORDER 25 0.0045
457 LIQUID PRODUCT PHYSICAL ISSUE 33 0.0045
458 MALAISE 1979 0.0045
459 MOUTH SWELLING 26 0.0045
460 DRY MOUTH 365 0.0045
461 PRURITUS 1723 0.0045
462 OCULAR DISCOMFORT 50 0.0044
463 CARDIOVASCULAR DISORDER 113 0.0044
464 HEPATIC ENZYME INCREASED 303 0.0044
465 PERIPHERAL COLDNESS 61 0.0044
466 VENTRICULAR EXTRASYSTOLES 46 0.0044
467 RESPIRATORY TRACT INFECTION 115 0.0044
468 FOOD ALLERGY 34 0.0044
469 HYPOAESTHESIA 658 0.0044
470 HORDEOLUM 19 0.0044
471 DERMATITIS CONTACT 50 0.0044
472 PAROSMIA 33 0.0044
473 HERPES ZOSTER 250 0.0043
474 COGNITIVE DISORDER 203 0.0043
475 SPINAL DISORDER 41 0.0043
476 BACK INJURY 47 0.0043
477 GASTROENTERITIS 63 0.0043
478 COLD SWEAT 76 0.0043
479 TENDON DISORDER 28 0.0043
480 ERUCTATION 83 0.0043
481 RHINITIS ALLERGIC 19 0.0043
482 FEELING OF BODY TEMPERATURE CHANGE 25 0.0043
483 SLEEP DISORDER 301 0.0043
484 CHEILITIS 23 0.0042
485 FEELING HOT 260 0.0042
486 MYASTHENIA GRAVIS 34 0.0042
487 GASTROENTERITIS VIRAL 76 0.0042
488 URINARY TRACT INFECTION 716 0.0042
489 DYSPNOEA 2364 0.0042
490 CHOKING SENSATION 23 0.0042
491 CHROMATURIA 94 0.0042
492 HYPERTENSION 881 0.0042
493 PRODUCT PRESCRIBING ERROR 99 0.0042
494 ABDOMINAL DISTENSION 433 0.0041
495 DISCOMFORT 253 0.0041
496 EYE SWELLING 154 0.0041
497 TOE AMPUTATION 21 0.0041
498 REFUSAL OF TREATMENT BY PATIENT 27 0.0041
499 SCAB 47 0.0041
500 PHARYNGITIS 51 0.0041
501 PARAESTHESIA 646 0.0041
502 NEOPLASM MALIGNANT 274 0.0041
503 GASTROINTESTINAL INFLAMMATION 32 0.0041
504 MULTIPLE ALLERGIES 32 0.0041
505 DIARRHOEA 2632 0.0041
506 JOINT INJURY 87 0.0041
507 RESTLESS LEGS SYNDROME 74 0.0041
508 PANCREATITIS 215 0.0041
509 POST PROCEDURAL INFECTION 33 0.0041
510 CHILLS 473 0.0040
511 SPINAL COLUMN STENOSIS 19 0.0040
512 SKIN ABRASION 19 0.0040
513 PALPITATIONS 470 0.0040
514 EXTRASYSTOLES 28 0.0040
515 SWELLING 374 0.0040
516 TOOTH FRACTURE 44 0.0040
517 CYSTITIS 127 0.0040
518 BLOOD URIC ACID INCREASED 23 0.0040
519 NIGHT SWEATS 128 0.0040
520 BLOOD GLUCOSE DECREASED 189 0.0039
521 HYPERLIPIDAEMIA 47 0.0039
522 SLEEP APNOEA SYNDROME 75 0.0039
523 BLADDER DISORDER 39 0.0039
524 APPETITE DISORDER 26 0.0039
525 FOOD POISONING 21 0.0039
526 GASTROINTESTINAL DISORDER 351 0.0039
527 ANAL INCONTINENCE 35 0.0039
528 SKIN DISCOLOURATION 178 0.0039
529 EAR INFECTION 103 0.0039
530 SPINAL OSTEOARTHRITIS 34 0.0039
531 NERVE INJURY 43 0.0039
532 GRIP STRENGTH DECREASED 34 0.0039
533 CARPAL TUNNEL SYNDROME 54 0.0039
534 BRONCHOSPASM 55 0.0039
535 FAECES SOFT 28 0.0038
536 BLOOD URINE PRESENT 73 0.0038
537 LYMPHADENOPATHY 136 0.0038
538 WRIST FRACTURE 46 0.0038
539 KIDNEY INFECTION 75 0.0038
540 THINKING ABNORMAL 71 0.0038
541 DRY EYE 190 0.0038
542 THIRST 68 0.0038
543 POST PROCEDURAL COMPLICATION 73 0.0038
544 PHARYNGITIS STREPTOCOCCAL 41 0.0038
545 HYPERAESTHESIA 31 0.0038
546 HEART RATE IRREGULAR 85 0.0038
547 BLOOD DISORDER 30 0.0037
548 GLAUCOMA 72 0.0037
549 JOINT SWELLING 451 0.0037
550 HUNGER 52 0.0037
551 HYPERSOMNIA 107 0.0037
552 COMPRESSION FRACTURE 20 0.0037
553 TONGUE DISORDER 27 0.0037
554 INCREASED APPETITE 71 0.0037
555 BALANCE DISORDER 321 0.0037
556 MENTAL IMPAIRMENT 90 0.0037
557 CHOLECYSTITIS ACUTE 21 0.0037
558 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 178 0.0037
559 SPINAL FRACTURE 74 0.0037
560 POOR QUALITY DEVICE USED 37 0.0037
561 SKIN SWELLING 32 0.0037
562 GASTRITIS 97 0.0037
563 WEIGHT DECREASED 1025 0.0037
564 HOT FLUSH 276 0.0037
565 BREAST PAIN 39 0.0037
566 IMMUNE SYSTEM DISORDER 48 0.0036
567 GALLBLADDER DISORDER 65 0.0036
568 SARS-COV-2 TEST POSITIVE 48 0.0036
569 COVID-19 635 0.0036
570 TOOTH EXTRACTION 45 0.0036
571 NEPHROLITHIASIS 165 0.0036
572 MIGRAINE 343 0.0036
573 GLOMERULAR FILTRATION RATE DECREASED 44 0.0036
574 UPPER LIMB FRACTURE 71 0.0036
575 HYPERHIDROSIS 459 0.0036
576 APPLICATION SITE PAIN 78 0.0035
577 GASTROOESOPHAGEAL REFLUX DISEASE 284 0.0035
578 FACIAL PARALYSIS 30 0.0035
579 INCORRECT DOSE ADMINISTERED 800 0.0035
580 DRUG INTOLERANCE 338 0.0035
581 VIRAL INFECTION 116 0.0035
582 ALOPECIA 684 0.0035
583 APHTHOUS ULCER 27 0.0035
584 DRUG DISPENSING ERROR 53 0.0035
585 DECREASED IMMUNE RESPONSIVENESS 34 0.0035
586 EPISTAXIS 258 0.0034
587 BLOOD POTASSIUM INCREASED 56 0.0034
588 FORMICATION 24 0.0034
589 MITRAL VALVE INCOMPETENCE 39 0.0034
590 HEAD INJURY 109 0.0034
591 BEDRIDDEN 45 0.0034
592 BONE DISORDER 62 0.0034
593 ENERGY INCREASED 20 0.0034
594 CHOKING 66 0.0034
595 VITREOUS FLOATERS 33 0.0034
596 DYSPEPSIA 330 0.0034
597 INTERVERTEBRAL DISC DEGENERATION 31 0.0033
598 LIGAMENT SPRAIN 33 0.0033
599 BLEPHAROSPASM 21 0.0033
600 LOWER LIMB FRACTURE 64 0.0033
601 LYMPHOEDEMA 23 0.0033
602 INTERNAL HAEMORRHAGE 38 0.0033
603 VISION BLURRED 456 0.0033
604 FEELING JITTERY 63 0.0033
605 SKIN ATROPHY 19 0.0033
606 POOR QUALITY SLEEP 71 0.0033
607 EYE PAIN 186 0.0033
608 BRAIN INJURY 33 0.0033
609 HICCUPS 27 0.0033
610 QUALITY OF LIFE DECREASED 44 0.0033
611 IMPAIRED WORK ABILITY 70 0.0033
612 DYSGEUSIA 242 0.0033
613 NAUSEA 2577 0.0033
614 IMPAIRED DRIVING ABILITY 37 0.0033
615 MYOCARDIAL ISCHAEMIA 37 0.0032
616 EYE PRURITUS 109 0.0032
617 DYSPHAGIA 307 0.0032
618 DYSURIA 119 0.0032
619 ERECTILE DYSFUNCTION 83 0.0032
620 ANKLE FRACTURE 50 0.0032
621 ROAD TRAFFIC ACCIDENT 135 0.0032
622 MUSCLE TWITCHING 74 0.0032
623 FALL 1068 0.0032
624 INSURANCE ISSUE 49 0.0032
625 HAEMORRHAGIC STROKE 25 0.0032
626 INCORRECT PRODUCT STORAGE 42 0.0032
627 SKIN REACTION 45 0.0032
628 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 227 0.0032
629 JOINT EFFUSION 22 0.0032
630 TOOTH INFECTION 42 0.0032
631 HIP FRACTURE 102 0.0032
632 BLINDNESS 129 0.0032
633 HEART RATE INCREASED 313 0.0032
634 MICTURITION URGENCY 36 0.0031
635 BLOOD THYROID STIMULATING HORMONE INCREASED 29 0.0031
636 TYPE 2 DIABETES MELLITUS 106 0.0031
637 ORAL DISORDER 23 0.0031
638 POOR QUALITY PRODUCT ADMINISTERED 33 0.0031
639 BLOOD PRESSURE FLUCTUATION 75 0.0031
640 DERMATITIS ALLERGIC 39 0.0031
641 IMPAIRED GASTRIC EMPTYING 42 0.0031
642 VITAMIN D DEFICIENCY 30 0.0031
643 ORAL HERPES 60 0.0031
644 PROSTATIC SPECIFIC ANTIGEN INCREASED 42 0.0030
645 FAECES DISCOLOURED 66 0.0030
646 CORONAVIRUS INFECTION 20 0.0030
647 GINGIVAL PAIN 24 0.0030
648 BLOOD MAGNESIUM DECREASED 26 0.0030
649 TEMPERATURE INTOLERANCE 31 0.0030
650 HYPERCHOLESTEROLAEMIA 29 0.0030
651 HYSTERECTOMY 26 0.0030
652 DISTURBANCE IN ATTENTION 160 0.0030
653 ASTHMA 335 0.0030
654 POSTOPERATIVE WOUND INFECTION 20 0.0030
655 ARRHYTHMIA 140 0.0030
656 ORAL DISCOMFORT 41 0.0029
657 CEREBRAL INFARCTION 72 0.0029
658 INSOMNIA 782 0.0029
659 ABNORMAL LOSS OF WEIGHT 20 0.0029
660 FREQUENT BOWEL MOVEMENTS 79 0.0029
661 INCORRECT ROUTE OF DRUG ADMINISTRATION 104 0.0029
662 TASTE DISORDER 59 0.0029
663 HERNIA 56 0.0029
664 ATRIAL FLUTTER 23 0.0029
665 SKIN DISORDER 96 0.0029
666 TOOTH DISORDER 64 0.0029
667 FLUID RETENTION 146 0.0029
668 LIP DRY 26 0.0029
669 NAIL DISORDER 25 0.0029
670 LOCALISED INFECTION 69 0.0029
671 CARDIAC FAILURE ACUTE 19 0.0028
672 BLISTER 160 0.0028
673 TOOTH ABSCESS 29 0.0028
674 EYE HAEMORRHAGE 38 0.0028
675 ATRIOVENTRICULAR BLOCK 22 0.0028
676 EXTRA DOSE ADMINISTERED 115 0.0028
677 HOSPICE CARE 28 0.0028
678 BLOOD PRESSURE SYSTOLIC INCREASED 55 0.0028
679 CHOLELITHIASIS 92 0.0028
680 PRODUCT DISTRIBUTION ISSUE 26 0.0028
681 IMPAIRED QUALITY OF LIFE 40 0.0028
682 ANGIOEDEMA 123 0.0028
683 FURUNCLE 22 0.0028
684 NEPHROTIC SYNDROME 19 0.0028
685 PANIC REACTION 20 0.0028
686 TRICUSPID VALVE INCOMPETENCE 22 0.0028
687 OSTEOARTHRITIS 117 0.0028
688 NODULE 36 0.0028
689 PULMONARY MASS 41 0.0027
690 TREMOR 456 0.0027
691 SKIN ULCER 71 0.0027
692 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 142 0.0027
693 FEEDING DISORDER 55 0.0027
694 VITAMIN D DECREASED 23 0.0027
695 HYPOKINESIA 39 0.0027
696 LIVER DISORDER 119 0.0027
697 HAND FRACTURE 19 0.0027
698 GASTROINTESTINAL INFECTION 24 0.0027
699 WEIGHT FLUCTUATION 28 0.0027
700 RENAL CYST 21 0.0026
701 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
702 SPEECH DISORDER 138 0.0026
703 EYE IRRITATION 151 0.0026
704 BLINDNESS UNILATERAL 37 0.0026
705 CONFUSIONAL STATE 422 0.0026
706 PROCEDURAL COMPLICATION 20 0.0026
707 PARALYSIS 37 0.0026
708 FUNGAL INFECTION 86 0.0026
709 DIPLOPIA 67 0.0026
710 EMPHYSEMA 26 0.0026
711 INFLAMMATION 133 0.0026
712 SENSITIVE SKIN 19 0.0026
713 ABNORMAL DREAMS 71 0.0026
714 ERYTHEMA 528 0.0026
715 HIATUS HERNIA 33 0.0025
716 ORAL PAIN 57 0.0025
717 PHOTOSENSITIVITY REACTION 42 0.0025
718 JOINT RANGE OF MOTION DECREASED 34 0.0025
719 FOOT DEFORMITY 28 0.0025
720 ALANINE AMINOTRANSFERASE INCREASED 155 0.0025
721 PROCEDURAL PAIN 70 0.0025
722 CONSTIPATION 549 0.0025
723 BLOOD PRESSURE DECREASED 166 0.0025
724 HYPERTHYROIDISM 36 0.0025
725 FLUSHING 252 0.0025
726 RHABDOMYOLYSIS 103 0.0025
727 ANXIETY 701 0.0025
728 APHASIA 74 0.0024
729 LEUKAEMIA 23 0.0024
730 CARDIAC MURMUR 21 0.0024
731 HYPERTENSIVE CRISIS 27 0.0024
732 ABDOMINAL PAIN 564 0.0024
733 GENERALISED OEDEMA 30 0.0024
734 PNEUMONIA 784 0.0024
735 HEART RATE DECREASED 85 0.0024
736 ANOSMIA 35 0.0024
737 AGEUSIA 60 0.0024
738 WOUND 67 0.0024
739 BLOOD UREA INCREASED 40 0.0024
740 SYNCOPE 239 0.0024
741 COVID-19 PNEUMONIA 28 0.0024
742 ECZEMA 124 0.0024
743 CARDIAC FAILURE 189 0.0024
744 RETCHING 50 0.0023
745 THERAPY CHANGE 23 0.0023
746 DERMATITIS 49 0.0023
747 DECREASED ACTIVITY 25 0.0023
748 SUPRAVENTRICULAR TACHYCARDIA 22 0.0023
749 PULMONARY THROMBOSIS 25 0.0023
750 NERVOUS SYSTEM DISORDER 71 0.0023
751 FOOT FRACTURE 43 0.0023
752 CARDIAC FAILURE CONGESTIVE 182 0.0023
753 OBESITY 36 0.0023
754 MIDDLE INSOMNIA 42 0.0022
755 DEPRESSED MOOD 117 0.0022
756 THROMBOSIS 178 0.0022
757 PRODUCT PACKAGING ISSUE 21 0.0022
758 PETECHIAE 23 0.0022
759 HAEMATOMA 57 0.0022
760 SALIVARY HYPERSECRETION 22 0.0022
761 LOWER RESPIRATORY TRACT INFECTION 100 0.0022
762 PRODUCT ODOUR ABNORMAL 23 0.0022
763 DEPRESSION 499 0.0022
764 BLOOD IRON DECREASED 26 0.0022
765 SENSORY DISTURBANCE 35 0.0022
766 INCONTINENCE 23 0.0022
767 ABDOMINAL PAIN LOWER 55 0.0022
768 DECREASED APPETITE 505 0.0022
769 SKIN EXFOLIATION 183 0.0022
770 ASPARTATE AMINOTRANSFERASE INCREASED 115 0.0022
771 CELLULITIS 109 0.0022
772 NIGHTMARE 74 0.0021
773 BODY TEMPERATURE DECREASED 21 0.0021
774 LOSS OF CONSCIOUSNESS 273 0.0021
775 HYPOTHYROIDISM 68 0.0021
776 LACERATION 20 0.0021
777 DISORIENTATION 84 0.0021
778 DEVICE DELIVERY SYSTEM ISSUE 58 0.0021
779 URINARY INCONTINENCE 62 0.0021
780 RIB FRACTURE 43 0.0021
781 BACTERIAL INFECTION 39 0.0021
782 LUNG DISORDER 101 0.0021
783 DEHYDRATION 274 0.0021
784 ORAL CANDIDIASIS 27 0.0020
785 OSTEOPOROSIS 84 0.0020
786 EYE INFECTION 23 0.0020
787 RENAL IMPAIRMENT 170 0.0020
788 CYST 25 0.0020
789 IMPAIRED HEALING 66 0.0020
790 SKIN FISSURES 39 0.0020
791 BLOOD POTASSIUM DECREASED 60 0.0020
792 HYPOPHAGIA 51 0.0020
793 SCAR 34 0.0020
794 THERAPEUTIC RESPONSE DECREASED 120 0.0020
795 DIABETES MELLITUS INADEQUATE CONTROL 35 0.0020
796 EATING DISORDER 42 0.0020
797 ANAPHYLACTIC REACTION 108 0.0020
798 LUNG NEOPLASM MALIGNANT 80 0.0019
799 COLON CANCER 29 0.0019
800 ABASIA 48 0.0019
801 LYMPHOMA 30 0.0019
802 INCORRECT PRODUCT ADMINISTRATION DURATION 42 0.0019
803 IRRITABILITY 116 0.0019
804 MUSCLE RIGIDITY 23 0.0019
805 PHOTOPHOBIA 36 0.0019
806 SKIN CANCER 41 0.0019
807 HYPOTONIA 19 0.0019
808 DRUG ADMINISTERED AT INAPPROPRIATE SITE 20 0.0019
809 ORTHOSTATIC HYPOTENSION 33 0.0019
810 NOCTURIA 23 0.0019
811 JOINT DISLOCATION 20 0.0019
812 SUDDEN DEATH 20 0.0019
813 POST PROCEDURAL HAEMORRHAGE 22 0.0019
814 PYREXIA 653 0.0019
815 GLOSSODYNIA 42 0.0019
816 OCULAR HYPERAEMIA 89 0.0019
817 DEVICE LEAKAGE 81 0.0019
818 HYPERGLYCAEMIA 68 0.0019
819 THERAPY PARTIAL RESPONDER 29 0.0019
820 DRUG EFFECT DECREASED 100 0.0019
821 INITIAL INSOMNIA 19 0.0018
822 FRACTURE 35 0.0018
823 DRY SKIN 246 0.0018
824 POLYNEUROPATHY 22 0.0018
825 VENTRICULAR TACHYCARDIA 30 0.0018
826 RED BLOOD CELL SEDIMENTATION RATE INCREASED 20 0.0018
827 VASCULITIS 21 0.0018
828 DEATH 1553 0.0018
829 ISCHAEMIC STROKE 32 0.0018
830 APATHY 26 0.0018
831 MENTAL DISORDER 77 0.0018
832 VOMITING 824 0.0018
833 FEAR 47 0.0017
834 DENTAL CARIES 19 0.0017
835 PRODUCT USE COMPLAINT 27 0.0017
836 RESTLESSNESS 62 0.0017
837 SKIN INFECTION 19 0.0017
838 SOMNOLENCE 341 0.0017
839 COLITIS 64 0.0017
840 PLATELET COUNT INCREASED 22 0.0017
841 IMMUNODEFICIENCY 25 0.0017
842 DYSARTHRIA 63 0.0017
843 HEPATIC CIRRHOSIS 31 0.0016
844 HAIR TEXTURE ABNORMAL 22 0.0016
845 PERICARDIAL EFFUSION 38 0.0016
846 BLOOD CREATININE INCREASED 107 0.0016
847 ULCER 26 0.0016
848 SYSTEMIC LUPUS ERYTHEMATOSUS 58 0.0016
849 LUNG INFECTION 25 0.0016
850 PANCREATITIS ACUTE 36 0.0016
851 PAIN OF SKIN 43 0.0016
852 HYPOTENSION 320 0.0016
853 EXPIRED PRODUCT ADMINISTERED 53 0.0016
854 RHEUMATOID ARTHRITIS 179 0.0016
855 CHRONIC KIDNEY DISEASE 119 0.0016
856 INTRAOCULAR PRESSURE INCREASED 20 0.0016
857 PULMONARY FIBROSIS 30 0.0016
858 CONJUNCTIVITIS 29 0.0016
859 APPLICATION SITE ERYTHEMA 40 0.0015
860 ANKYLOSING SPONDYLITIS 20 0.0015
861 STAPHYLOCOCCAL INFECTION 50 0.0015
862 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
863 PRODUCT PRESCRIBING ISSUE 33 0.0015
864 SKIN LESION 41 0.0015
865 MALIGNANT MELANOMA 20 0.0015
866 PRODUCT DOSE OMISSION IN ERROR 42 0.0015
867 LIVER INJURY 36 0.0015
868 PANIC ATTACK 53 0.0015
869 PSORIATIC ARTHROPATHY 59 0.0015
870 OEDEMA 78 0.0014
871 PRODUCT PHYSICAL ISSUE 29 0.0014
872 ANAPHYLACTIC SHOCK 37 0.0014
873 BLOOD SODIUM DECREASED 27 0.0014
874 PELVIC PAIN 26 0.0014
875 PERICARDITIS 24 0.0014
876 CANDIDA INFECTION 24 0.0014
877 BASAL CELL CARCINOMA 22 0.0014
878 LIVER FUNCTION TEST ABNORMAL 41 0.0014
879 URINARY RETENTION 46 0.0014
880 COORDINATION ABNORMAL 19 0.0014
881 INFECTION 197 0.0014
882 PULMONARY OEDEMA 60 0.0013
883 DRUG-INDUCED LIVER INJURY 42 0.0013
884 STOMATITIS 81 0.0013
885 BODY TEMPERATURE INCREASED 27 0.0013
886 MOOD ALTERED 36 0.0013
887 OSTEOPENIA 20 0.0013
888 OEDEMA PERIPHERAL 160 0.0013
889 HAEMORRHAGE 137 0.0013
890 SEPSIS 145 0.0013
891 EMOTIONAL DISORDER 40 0.0013
892 BREAST CANCER 120 0.0013
893 CEREBRAL HAEMORRHAGE 46 0.0013
894 HAEMORRHOIDS 25 0.0013
895 TREATMENT NONCOMPLIANCE 70 0.0013
896 HAEMATOCHEZIA 70 0.0013
897 GASTRIC ULCER 24 0.0013
898 HYPOGLYCAEMIA 61 0.0013
899 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
900 HEMIPARESIS 21 0.0012
901 C-REACTIVE PROTEIN INCREASED 45 0.0012
902 MOUTH ULCERATION 26 0.0012
903 SKIN BURNING SENSATION 88 0.0012
904 RENAL FAILURE 163 0.0012
905 FEMUR FRACTURE 38 0.0012
906 CARDIAC ARREST 101 0.0012
907 INTESTINAL OBSTRUCTION 46 0.0012
908 THERAPEUTIC RESPONSE SHORTENED 40 0.0012
909 DRUG PRESCRIBING ERROR 23 0.0012
910 TACHYCARDIA 106 0.0012
911 DRUG ERUPTION 21 0.0012
912 HEPATIC FUNCTION ABNORMAL 44 0.0012
913 HAEMOPTYSIS 32 0.0011
914 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
915 ANGER 38 0.0011
916 PLEURAL EFFUSION 68 0.0011
917 PSORIASIS 145 0.0011
918 PROSTATE CANCER 88 0.0011
919 RESPIRATORY DISTRESS 30 0.0011
920 DRUG INEFFECTIVE 1432 0.0011
921 HAEMATURIA 37 0.0011
922 TRANSAMINASES INCREASED 24 0.0011
923 HEPATITIS 27 0.0011
924 OXYGEN SATURATION DECREASED 59 0.0010
925 OSTEOMYELITIS 19 0.0010
926 RECTAL HAEMORRHAGE 45 0.0010
927 SEIZURE 120 0.0010
928 MOVEMENT DISORDER 33 0.0010
929 RED BLOOD CELL COUNT DECREASED 29 0.0010
930 SKIN IRRITATION 45 0.0010
931 PANCREATIC CARCINOMA 28 0.0010
932 PRODUCT AVAILABILITY ISSUE 22 0.0010
933 ACTIVITIES OF DAILY LIVING IMPAIRED 19 0.0010
934 PULMONARY EMBOLISM 91 0.0010
935 ACNE 72 0.0009
936 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
937 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
938 DEEP VEIN THROMBOSIS 61 0.0009
939 DYSKINESIA 38 0.0009
940 PALLOR 25 0.0009
941 COLITIS ULCERATIVE 41 0.0009
942 ANAEMIA 174 0.0009
943 MOOD SWINGS 29 0.0009
944 CRYING 33 0.0009
945 CONDITION AGGRAVATED 276 0.0009
946 HALLUCINATION 68 0.0009
947 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
948 INJURY 61 0.0009
949 DRUG RESISTANCE 22 0.0009
950 BRADYCARDIA 45 0.0008
951 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
952 AGITATION 62 0.0008
953 BLADDER CANCER 49 0.0008
954 PRODUCT USE ISSUE 155 0.0008
955 GASTROINTESTINAL HAEMORRHAGE 68 0.0008
956 INTENTIONAL PRODUCT USE ISSUE 71 0.0008
957 GENERAL PHYSICAL HEALTH DETERIORATION 91 0.0008
958 BREAST CANCER FEMALE 21 0.0008
959 DERMATITIS ATOPIC 41 0.0008
960 MULTIPLE SCLEROSIS 37 0.0008
961 HAEMOGLOBIN DECREASED 79 0.0008
962 BLOOD BILIRUBIN INCREASED 20 0.0007
963 SUICIDAL IDEATION 67 0.0007
964 INTERSTITIAL LUNG DISEASE 35 0.0007
965 DISEASE RECURRENCE 34 0.0007
966 ACUTE KIDNEY INJURY 103 0.0007
967 CARDIO-RESPIRATORY ARREST 28 0.0007
968 DISEASE PROGRESSION 78 0.0007
969 DRUG INTERACTION 101 0.0006
970 EPILEPSY 19 0.0006
971 DEVICE BREAKAGE 25 0.0006
972 PLASMA CELL MYELOMA 24 0.0006
973 HYPOXIA 21 0.0006
974 HYPOKALAEMIA 27 0.0006
975 VISUAL ACUITY REDUCED 19 0.0006
976 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
977 PLATELET COUNT DECREASED 58 0.0005
978 PRODUCT USE IN UNAPPROVED INDICATION 126 0.0005
979 VAGINAL HAEMORRHAGE 22 0.0005
980 ACCIDENTAL OVERDOSE 18 0.0005
981 HYPONATRAEMIA 26 0.0005
982 THROMBOCYTOPENIA 49 0.0004
983 RESPIRATORY FAILURE 31 0.0004
984 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
985 PRODUCT SUBSTITUTION ISSUE 22 0.0004
986 TREATMENT FAILURE 31 0.0004
987 AGGRESSION 18 0.0004
988 EMOTIONAL DISTRESS 38 0.0003
989 PRODUCT QUALITY ISSUE 39 0.0003
990 OVERDOSE 44 0.0002
991 NO ADVERSE EVENT 32 0.0002